Catecholamine levels and pacing behavior of QT-driven pacemakers during exercise

Area of Science:

• Cardiology
• Electrophysiology
• Pharmacology

Background:

• Catecholamines, such as adrenaline and noradrenaline, are implicated in cardiac repolarization and pacemaker function.
• QT-driven pacemakers adjust pacing based on cardiac repolarization time.

Purpose of the Study:

• To investigate the correlation between plasma catecholamine levels and the pacing rate of modern QT-driven pacemakers.
• To determine whether adrenaline or noradrenaline is more closely associated with pacemaker pacing behavior.

Main Methods:

• Plasma levels of adrenaline and noradrenaline were measured in eight patients (age 54-85) at rest, during exercise, and during recovery.
• Pacemaker pacing rates were recorded and analyzed in conjunction with catecholamine levels.
• Statistical analysis, including correlation coefficients, was used to assess relationships.

Main Results:

• Noradrenaline (NA) levels significantly increased during exercise and recovery, while adrenaline levels did not.
• A strong positive correlation was found between mean NA levels and mean pacing rate during exercise and recovery (r=0.963, P<0.0001).
• Changes in pacing rate also strongly correlated with changes in NA levels (r=0.882, P<0.005), but not with adrenaline levels.

Conclusions:

• The pacing rate of contemporary QT-driven pacemakers is primarily influenced by noradrenaline levels, not adrenaline.
• Noradrenaline spillover into the plasma is a key determinant of pacemaker pacing behavior.
• Pacemaker adaptation to physiological changes shows a slight delay of less than one minute.